Related by context. Frequent words. (Click for all words.) 64 Issues Guidance 63 Provides Guidance 63 Clinical Trial Results 62 Annual Meeting Date 62 2nd Quarter Results 62 FY# Guidance 61 Shareholder Letter 61 Resp 61 Significantly Reduces 61 Deadline Approaches 61 FDA Accepts 60 1st Quarter Results 60 Summarizes 60 Proposed Changes 60 Shareholder Vote 60 4Q Loss Widens 60 Provides Updates 60 Guidance Quick Facts 60 Previously Announced 60 Compl 60 Patient Enrollment 60 Revenues Decline 60 Full Prescribing Information 60 Shelf Registration Statement 60 Reduces Risk 60 Outlook Revised 59 Receives Positive 59 Stock Buyback 59 Share Repurchases 59 Cholesterol Drug 59 Trading Activity 59 Dkt 59 A.M. Best 59 Smallpox Vaccine 59 Issues Statement Regarding 59 Significant Increase 59 Drug Makers 59 Patent Lawsuit 59 Q2 Loss Narrows 59 Lowers Guidance 59 Forecast Quick Facts 59 3rd Quarter Results 59 Notice Regarding 58 Updates Guidance 58 Deadline Approaching 58 Completes Tender Offer 58 Phase III Trial 58 Below Consensus 58 Complete Merger 58 Option Grants 58 Lower Than Expected 58 Comment Period 58 Updates Shareholders 58 Study Demonstrates 58 Q4 Loss Widens 58 Files Annual Report 58 Extends Offer 58 Dividend Payment 58 Guides Q4 58 Guides Q2 58 FDA Clears 58 Quarter Results 58 Drug Candidate 58 Higher Than Expected 58 END FOOTNOTE 58 Q1 Loss Widens 58 #.#/Share [002] 58 CFO Resigns 58 Q4 Loss Narrows 58 www.dundeereit.com 57 Patent Infringement Lawsuit 57 Generic Version 57 FDA Clearance 57 Rate Hikes 57 Reaffirms Guidance 57 Tax Rebates 57 Regulators Approve 57 Q2 Loss Widens 57 Prescribing Information 57 Rating Methodology 57 Q3 Loss Widens 57 Host Webcast 57 Prostate Cancer Patients 57 Reporting Requirements 57 Extends Deadline 57 Announces Presentation 57 4th Quarter Earnings 57 Q1 Profit Declines 57 Extends Tender Offer 57 1st Quarter Earnings 57 Cell Phone Users 57 Litig 57 Regains Compliance 57 Merger Proposal 57 Regains Compliance With 57 Upcoming Conferences 57 Bankruptcy Filing 57 Provides Comprehensive 57 Q2 Profit Surges 57 Q3 Loss Narrows 57 Holds Annual Meeting